TCRX: TScan Therapeutics, Inc. Stock

by  •  • Comments Off on TCRX: TScan Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 97.30
Enterprise Value ($M) -49.31
Book Value ($M) 240.97
Book Value / Share 4.61
Price / Book 0.40
NCAV ($M) 162.57
NCAV / Share 3.11
Price / NCAV 0.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.85

Liquidity (mrq)
Quick Ratio 8.14
Current Ratio 8.14

Balance Sheet (mrq) ($M)
Current Assets 292.72
Assets 371.12
Liabilities 130.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.82
Operating Income -134.82
Net Income -127.50

Cash Flow Statement (mra) ($M)
Cash From Operations -110.82
Cash from Investing -52.61
Cash from Financing 208.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Lynx1 Capital Management LP 10.90 -94.59
02-14 13G/A K2 HealthVentures Equity Trust LLC 6.90 -32.33
02-12 13G/A Adage Capital Partners Gp, L.l.c. 7.13 -10.26
11-14 13G/A Cormorant Asset Management, LP 0.00 -100.00
11-14 13G/A Biotechnology Value Fund L P 9.99 14.91
11-08 13G BlackRock, Inc. 9.50 0.00
04-23 13D/A Baker Bros. Advisors Lp 6.10 1.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-05 10-K Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-10 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ T

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 70,087 308,162 22.74
2025-03-10 72,749 380,949 19.10
2025-03-07 63,447 191,181 33.19
2025-03-06 46,637 176,457 26.43

(click for more detail)

Similar Companies
SUPN – Supernus Pharmaceuticals, Inc. TARA – Protara Therapeutics, Inc.
TBPH – Theravance Biopharma, Inc. TKNO – Alpha Teknova, Inc.
TLPH – Talphera, Inc.


Financial data and stock pages provided by
Fintel.io